Lurie Children’s Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois

FHS
April 3, 2024
6:14 pm

On March 27, 2024, Ann & Robert H. Lurie Children’s Hospital of Chicago treated its first patient with ELEVIDYS (delandistrogene moxeparvovec-rokl), the first gene therapy for Duchenne muscular dystrophy – a rare, genetic disease characterized by progressive muscle damage and weakness.

Steward Health Care CEO Ralph de la Torre will resign

Dr. Ralph de la Torre, a former heart surgeon who built and became the face of Steward Health Care and its network of neglected hospitals, is stepping down

September 29, 2024

Qure.ai Raises $65M to Expand Healthcare AI Solutions Globally

What You Should Know: – Qure.ai, a prominent global innovator in healthcare AI, has successfully closed a $65M in Series D funding round led by

September 25, 2024

Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant

Dive Brief: Smith & Nephew struck an agreement last week to buy CartiHeal for $180 million upfront to expand its range of sports medicine technologies. CartiHeal received

November 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.